Cite
HARVARD Citation
Canaud, G. et al. (2013). Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes. American journal of transplantation. 13 (8), pp. 2179-2185. [Online].